Jaffe GJ - Search Results

1

Ashton P, Blandford DL, Pearson PA, Jaffe GJ, Martin DF, Nussenblatt RB. Ashton P, et al. Among authors: jaffe gj. J Ocul Pharmacol. 1994 Winter;10(4):691-701. doi: 10.1089/jop.1994.10.691. J Ocul Pharmacol. 1994. PMID: 7714413 Review.

2

Removal of optic disc stalks during diabetic vitrectomy.

Pendergast SD, Martin DF, Proia AD, Jaffe GJ, McCuen BW 2nd. Pendergast SD, et al. Among authors: jaffe gj. Retina. 1995;15(1):25-8. doi: 10.1097/00006982-199515010-00005. Retina. 1995. PMID: 7754243

3

Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.

Cheng CK, Berger AS, Pearson PA, Ashton P, Jaffe GJ. Cheng CK, et al. Among authors: jaffe gj. Invest Ophthalmol Vis Sci. 1995 Feb;36(2):442-53. Invest Ophthalmol Vis Sci. 1995. PMID: 7843913

4

Treatment and pathogenesis of traumatic chorioretinal rupture (sclopetaria).

Martin DF, Awh CC, McCuen BW 2nd, Jaffe GJ, Slott JH, Machemer R. Martin DF, et al. Among authors: jaffe gj. Am J Ophthalmol. 1994 Feb 15;117(2):190-200. doi: 10.1016/s0002-9394(14)73076-4. Am J Ophthalmol. 1994. PMID: 8116747

5

Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome.

Pearson PA, Jaffe GJ, Ashton P. Pearson PA, et al. Among authors: jaffe gj. Am J Ophthalmol. 1993 May 15;115(5):686-8. doi: 10.1016/s0002-9394(14)71487-4. Am J Ophthalmol. 1993. PMID: 8387726 No abstract available.

6

Evaluation of a delivery system providing long-term release of cyclosporine.

Pearson PA, Jaffe GJ, Martin DF, Cordahi GJ, Grossniklaus H, Schmeisser ET, Ashton P. Pearson PA, et al. Among authors: jaffe gj. Arch Ophthalmol. 1996 Mar;114(3):311-7. doi: 10.1001/archopht.1996.01100130307014. Arch Ophthalmol. 1996. PMID: 8600892

7

An intravitreal device providing sustained release of cyclosporine and dexamethasone.

Enyedi LB, Pearson PA, Ashton P, Jaffe GJ. Enyedi LB, et al. Among authors: jaffe gj. Curr Eye Res. 1996 May;15(5):549-57. doi: 10.3109/02713689609000766. Curr Eye Res. 1996. PMID: 8670756

8

Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.

Berger AS, Cheng CK, Pearson PA, Ashton P, Crooks PA, Cynkowski T, Cynkowska G, Jaffe GJ. Berger AS, et al. Among authors: jaffe gj. Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2318-25. Invest Ophthalmol Vis Sci. 1996. PMID: 8843916

9

Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.

Jaffe GJ, Yang CS, Wang XC, Cousins SW, Gallemore RP, Ashton P. Jaffe GJ, et al. Ophthalmology. 1998 Jan;105(1):46-56. doi: 10.1016/s0161-6420(98)91176-9. Ophthalmology. 1998. PMID: 9442778 Free article.

10

An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.

Yang CS, Khawly JA, Hainsworth DP, Chen SN, Ashton P, Guo H, Jaffe GJ. Yang CS, et al. Among authors: jaffe gj. Arch Ophthalmol. 1998 Jan;116(1):69-77. doi: 10.1001/archopht.116.1.69. Arch Ophthalmol. 1998. PMID: 9445210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

354 results

Search Page